Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.84 USD -2.65% Market Closed
Market Cap: $52.4m

Wall Street
Price Targets

IDXG Price Targets Summary
Interpace Biosciences Inc

There are no price targets for IDXG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Interpace Biosciences Inc Competitors:
Price Targets
YUMC
Yum China Holdings Inc
30% Upside
TNDM
Tandem Diabetes Care Inc
68% Upside
CNC
Concurrent Technologies PLC
41% Upside
SRFM
Surf Air Mobility Inc
576% Upside

Revenue
Forecast

-9% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
-9% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 13 years the compound annual growth rate for Interpace Biosciences Inc's revenue is -9%. The projected CAGR for the next 3 years is -1%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDXG's stock price target?
Not Available

IDXG doesn't have any price targets made by Wall Street professionals.

What is Interpace Biosciences Inc's Revenue forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Interpace Biosciences Inc's revenue is -9%. The projected CAGR for the next 3 years is -1%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett